Document:

EX-10.2

 Exhibit 10.2 

DEBT EXCHANGE AGREEMENT 

This Debt Exchange Agreement (this “Agreement”) is dated as of December 16, 2020, between Alphatec Holdings, Inc., a
Delaware corporation (the “Company”), and Squadron Capital LLC, a Delaware limited liability company (“Lead Purchaser”). 

WHEREAS, the Company, certain of its subsidiaries, and Squadron Medical Finance Solutions LLC, as lender and an affiliate of Lead Purchaser,
have entered into that certain Third Amendment, dated on or about the date hereof (the “Third Amendment”), to that certain Credit, Security and Guaranty Agreement, dated as of November 6, 2018 by and among the Company, certain
of its subsidiaries and Lead Purchaser (as amended, the “Existing Credit Agreement”), pursuant to which, among other things, the Company and Lead Purchaser desire to exchange $30,000,000 of the Existing Term Loan (as defined in the
Existing Credit Agreement) for shares of common stock of the Company, par value $0.0001 per share (“Common Stock”); 

WHEREAS, the Company, Lead Purchaser and certain other purchasers (the “SPA Purchasers”) have entered into that certain
Securities Purchase Agreement, dated on or about the date hereof (as the same may be amended from time to time, the “Securities Purchase Agreement”), pursuant to which the Company will sell and issue to the SPA Purchasers shares of
Common Stock; 
 WHEREAS, in connection with the Securities Purchase Agreement and this Agreement, the Company, Lead Purchaser and the SPA
Purchasers have entered into that certain Registration Rights Agreement, dated on or about the date hereof (as the same may be amended from time to time, the “Registration Rights Agreement,”), pursuant to which the Company will
agree to provide certain registration rights in respect of the shares of Common Stock of the Company sold hereunder and thereunder; and 

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933,
as amended (the “Securities Act”), and/or Rule 506 of Regulation D promulgated thereunder, the Company desires to issue to Lead Purchaser a number of shares of its Common Stock, and, in exchange, Lead Purchaser desires to transfer
to the Company $30,000,000 of outstanding debt obligations under the Existing Term Loan, as more fully described in this Agreement. 
 NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows: 

ARTICLE I. 
 DEFINITIONS

 1.1 Definitions. In addition to the terms defined elsewhere in this Agreement the following terms have the meanings set forth
in this Section 1.1: 
 “Affiliate” means any Person that, directly or indirectly through one or more
intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act. 

 “Board of Directors” means the board of directors of the
Company. 
 “Business Day” means any day except any Saturday, any Sunday, any day which is a federal legal
holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close. 

“Closing” means the closing of the Debt Exchange pursuant to Section 2.1. 

“Closing Date” means the Trading Day on which all of the Transaction Documents have been executed and
delivered by the applicable parties thereto, and all conditions precedent to (i) Lead Purchaser’s obligations and (ii) the Company’s obligations to deliver the Shares, in each case, have been satisfied or waived, with such date
to be agreed to by the Company and Lead Purchaser but (i) in no event earlier than the second business day after the date hereof and (ii) in no event later than the fifth business day after the date hereof. 

“Commission” means the United States Securities and Exchange Commission. 

“Common Stock” shall have the meaning ascribed to such term in the Recitals. 

“Company Counsel” means Latham & Watkins LLP, with offices located at 12670 High Bluff Drive, San
Diego, California 92310. 
 “Debt Exchange” shall have the meaning ascribed to such term in
Section 2.1. 
 “Disclosure Schedules” shall have the meaning ascribed to such term in the Securities
Purchase Agreement. 
 “Effective Date” means the earliest of the date that (a) the initial
Registration Statement has been declared effective by the Commission, (b) all of the Shares have been sold pursuant to Rule 144 or may be sold pursuant to Rule 144 without the requirement for the Company to be in compliance with the current
public information required under Rule 144 and without volume or manner-of-sale restrictions, (c) following the one-year
anniversary of the Closing Date provided that no holder of Shares is an Affiliate of the Company, (d) all of the Shares may be sold pursuant to an exemption from registration under Section 4(a)(1) of the Securities Act without volume or manner-of-sale restrictions and Company Counsel has delivered to such holders a standing written unqualified opinion that resales may then be made by such holders of the
Shares pursuant to such exemption which opinion shall be in form and substance reasonably acceptable to such holders or (e) such date as agreed to in writing by the Company and the Lead Purchaser. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations
promulgated thereunder. 
 “Lead Purchaser Party” shall have the meaning ascribed to such term in
Section 4.3. 

  
 2 

 “Nasdaq” means the Nasdaq Stock Market LLC. 

“Per Share Purchase Price” equals $11.11. 

“Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association,
joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind. 

“Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an
informal investigation or partial proceeding, such as a deposition), whether commenced or threatened. 

“Registration Rights Agreement” shall have the meaning ascribed to such term in the Recitals. 

“Registration Statement” means a registration statement meeting the requirements set forth in the Registration
Rights Agreement and covering the resale by the Lead Purchaser of the Shares. 
 “Rule 144” means Rule 144
promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as
such Rule. 
 “SEC Reports” shall have the meaning ascribed to such term in the Securities Purchaser
Agreement. 
 “Securities Act” shall have the meaning ascribed to such term in the Recitals. 

“Securities Purchase Agreement” shall have the meaning ascribed to such term in the Recitals. 

“Shares” shall have the meaning ascribed to such term in the Recitals. 

“Short Sales” means all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange
Act (but shall not be deemed to include the location and/or reservation of borrowable shares of Common Stock). 

“SPA Purchasers” shall have the meaning ascribed to such term in the Recitals. 

“Subsidiary” means any subsidiary of the Company as set forth on Schedule 3.1(a) and shall, where
applicable, also include any direct or indirect subsidiary of the Company formed or acquired after the date hereof. 

“Trading Day” means a day on which the principal Trading Market is open for trading. 

  
 3 

 “Trading Market” means any of the following markets or
exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange (or any successors to any of
the foregoing). 
 “Transaction Documents” means this Agreement, the Third Amendment, the Registration
Rights Agreement, all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder. 

“Transfer Agent” means Computershare, Inc., the current transfer agent of the Company, with a mailing address
of 480 Washington Avenue, Jersey City, New Jersey 07310, and any successor transfer agent of the Company. 
 ARTICLE II. DEBT EXCHANGE

 2.1 Debt Exchange. On the Closing Date, upon the terms and subject to the conditions set forth herein, (a) the Company
shall issue to Lead Purchaser 2,700,270 shares of Common Stock (the “Shares”), and Lead Purchaser shall accept such Shares, and, in exchange (b) Lead Purchaser shall transfer to the Company the principal amount of
$30,000,000 of outstanding debt obligations under the Existing Term Loan, and the Company shall accept and retire such outstanding debt obligations (collectively, the “Debt Exchange”). The number of Shares to be received by Lead
Purchaser was determined by dividing $30,000,000 by the Per Share Purchase Price and rounding down to the nearest whole share. The Company shall deliver the Shares to Lead Purchaser, and the Company and Lead Purchaser shall deliver the other items
set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur remotely via exchange of documents and signatures. 

2.2 Deliveries. 

(a) On or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following: 

(i) this Agreement duly executed by the Company; 

(ii) a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver, on an expedited
basis, a certificate or in book entry form, at Lead Purchaser’s election (unless Lead Purchaser indicates otherwise, Shares shall be delivered in book entry form), evidencing the Shares, with 50% of the Shares registered in the name of Lead
Purchaser and 50% of the Shares registered in the name of Tawani Holdings LLC, so long as Tawani Holdings LLC makes customary representations and warranties to the Company prior to the Closing Date with respect to such issuance; 

(iii) the Third Amendment and the Third Amended and Restated Term Note (as defined in the Third Amendment), each duly executed
by the Company; and the Registration Rights Agreement duly executed by the Company. 

  
 4 

 (b) On or prior to the Closing Date, Lead Purchaser shall deliver or cause
to be delivered to the Company the following: 
 (i) this Agreement duly executed by Lead Purchaser; 

(ii) the Third Amendment and the Third Amended and Restated Term Note (as defined in the Third Amendment), each duly executed
by Lead Purchaser; and 
 (iii) the Registration Rights Agreement duly executed by Lead Purchaser. 

2.3 Closing Conditions.  

(a) The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:

 (i) the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or
Material Adverse Effect, in all respects) on the Closing Date of the representations and warranties of Lead Purchaser contained herein (unless as of a specific date therein in which case they shall be accurate as of such date); 

(ii) all obligations, covenants and agreements of Lead Purchaser required to be performed at or prior to the Closing Date shall
have been performed in all material respects; 
 (iii) no stop order or suspension of trading shall have been imposed by
Nasdaq, the SEC or any other governmental or regulatory body with respect to public trading in the Common Stock; and 
 (iv)
the delivery by Lead Purchaser of the items set forth in Section 2.2(b) of this Agreement. 
 (b) The respective
obligations of Lead Purchaser hereunder in connection with the Closing are subject to the following conditions being met: 

(i) the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or
Material Adverse Effect, in all respects) as of the date of this Agreement of the representations and warranties of the Company contained herein (unless as of a specific date therein in which case they shall be accurate as of such date); 

(ii) all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall
have been performed in all material respects; 
 (iii) no stop order or suspension of trading shall have been imposed by
Nasdaq, the SEC or any other governmental or regulatory body with respect to public trading in the Common Stock; 

  
 5 

 (iv) the Company shall have filed with Nasdaq a Supplemental Listing
Application for the listing of the Shares, and Nasdaq shall have raised no objection to the consummation of the transactions contemplated by the Transaction Documents; and 

(v) the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement. 

ARTICLE III. 

REPRESENTATIONS AND WARRANTIES 

3.1 Representations and Warranties of the Company. Except as set forth in the Disclosure Schedules, the Company hereby confirms that
the representations and warranties contained in Section 3.1 of the Securities Purchase Agreement are true and correct as of the date hereof as though made pursuant to this Agreement. 

3.2 Representations and Warranties of Lead Purchaser. Lead Purchaser hereby confirms that the representations and warranties contained
in Section 3.2 of the Securities Purchase Agreement as they relate severally to Lead Purchaser and not to any other purchaser thereunder are true and correct as of the date hereof as though made by Lead Purchaser pursuant to this Agreement.

 ARTICLE IV. 
 OTHER
AGREEMENTS OF THE PARTIES 
 4.1 Transfer Restrictions. 

(a) The Shares may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of
Shares other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of Lead Purchaser, the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the
transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Shares under the
Securities Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and the Registration Rights Agreement and shall have the rights and obligations of Lead Purchaser under this Agreement
and the Registration Rights Agreement. 
 (b) Lead Purchaser agrees to the imprinting, so long as is required by this
Section 4.1, of a legend on any of the Shares in the following form: 
 THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND
EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT
TO AN 

  
 6 

 
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND
IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. 
 (c) Certificates evidencing the Shares shall not contain any legend
(including the legend set forth in Section 4.1(b) hereof), (i) while a registration statement (including the Registration Statement) covering the resale of such security is effective under the Securities Act, (ii) following any sale of
such Shares pursuant to Rule 144, (iii) if such Shares are eligible for sale under Rule 144, without the requirement for the Company to be in compliance with the current public information required under Rule 144 as to such Shares without volume or manner-of-sale restrictions, or (iv) if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and
pronouncements issued by the staff of the Commission). The Company shall cause its counsel to issue a legal opinion to the Transfer Agent promptly after the Effective Date if required by the Transfer Agent to effect the removal of the legend
hereunder. The Company agrees that following the Effective Date or at such time as such legend is no longer required under this Section 4.1(c), it will, no later than the earlier of (i) two (2) Trading Days and (ii) the number of
Trading Days comprising the Standard Settlement Period (as defined below) following the delivery by Lead Purchaser to the Company or the Transfer Agent of a certificate representing Shares, as the case may be, issued with a restrictive legend,
deliver or cause to be delivered to Lead Purchaser a certificate representing such shares that is free from all restrictive and other legends. The Company may not make any notation on its records or give instructions to the Transfer Agent that
enlarge the restrictions on transfer set forth in this Section 4.1. Certificates for Shares subject to legend removal hereunder shall be transmitted by the Transfer Agent to Lead Purchaser by crediting the account of Lead Purchaser’s prime
broker with the Depository Trust Company System as directed by Lead Purchaser. As used herein, “Standard Settlement Period” means the standard settlement period, expressed in a number of Trading Days, on the Company’s primary
Trading Market with respect to the Common Stock as in effect on the date of delivery of a certificate representing Shares, issued with a restrictive legend. 

(d) Lead Purchaser agrees with the Company that Lead Purchaser will sell any Shares pursuant to either the registration
requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if Shares are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution
set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Shares as set forth in this Section 4.1 is predicated upon the Company’s reliance upon this understanding. 

4.2 Furnishing of Information; Public Information. Until Lead Purchaser owns no Shares, the Company covenants to maintain the
registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the
date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act. 

  
 7 

 4.3 Indemnification of Lead Purchaser. Subject to the provisions of this
Section 4.3, the Company will indemnify and hold Lead Purchaser and its directors, officers, shareholders, members, partners, trustees, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such
titles notwithstanding a lack of such title or any other title), each Person who controls Lead Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers,
shareholders, agents, members, partners, trustees, employees or agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons
(each, a “Lead Purchaser Party”) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable
attorneys’ fees and costs of investigation that any such Lead Purchaser Party may suffer or incur as a result of or relating to any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement
or in the other Transaction Documents. If any action shall be brought against any Lead Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the
Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Lead Purchaser Party. Any Lead Purchaser Party shall have the right to employ separate counsel in any such action and
participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Lead Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing,
(ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel to the Lead Purchaser Party, a material conflict on any
material issue between the position of the Company and the position of such Lead Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be
liable to any Lead Purchaser Party under this Agreement (y) for any settlement by a Lead Purchaser Party effected without the Company’s prior written consent, which shall not be unreasonably withheld or delayed; or (z) to the extent,
but only to the extent that a loss, claim, damage or liability is attributable to (A) any conduct by such Lead Purchaser Party which has been finally judicially determined to constitute fraud, gross negligence or willful misconduct or
(B) such Lead Purchaser Party’s breach of a representation, warranty, covenant or agreement made by or to be performed on the part of such Lead Purchaser Party under the Transaction Documents. The indemnification required by this
Section 4.3 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any cause
of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law. 

4.4 Listing of Common Stock. The Company shall, if applicable: (i) in the time and manner required by the principal Trading Market,
prepare and file with such Trading Market an additional shares listing application covering the Shares, (ii) provide to the Lead Purchaser evidence of such additional shares listing application and (iii) maintain the listing or quotation
of such Common Stock on such Trading Market or another Trading Market. The Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation,
including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer. 

  
 8 

 4.5 Form D; Blue Sky Filings. The Company agrees to timely file a Form D with respect
to the Shares as required under Regulation D and to provide a copy thereof, promptly upon request of Lead Purchaser. The Company shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to
qualify the Shares for, sale to Lead Purchaser at the Closing under applicable securities or “Blue Sky” laws of the states of the United States, and shall provide evidence of such actions promptly upon request of Lead Purchaser. 

ARTICLE V. 

MISCELLANEOUS 
 5.1
Termination. This Agreement may be terminated by Lead Purchaser by written notice to the Company, if the Closing has not been consummated on or before January 15, 2021; provided, that such termination will not affect the
right of any party to sue for any breach by any other party (or parties). 
 5.2 Fees and Expenses. Except as otherwise expressly set
forth in the Transaction Documents and the Securities Purchase Agreement to the contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party
incident to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for same-day
processing of any instruction letter delivered by the Company and any exercise notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Shares to Lead Purchaser. 

5.3 Entire Agreement. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of
the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and
schedules. 
 5.4 Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder
shall be in writing and shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication is delivered via facsimile or email attachment at the facsimile number or email address as set forth
on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile or email address at the
facsimile number or email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given.
The address for such notices and communications shall be as set forth on the signature pages attached hereto. 

  
 9 

 5.5 Amendments; Waivers. No provision of this Agreement may be waived, modified,
supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company and Lead Purchaser, in the case of a waiver, by the party against whom enforcement of any such waived provision is sought. No waiver of any
default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor
shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. Any amendment effected in accordance with accordance with this Section 5.5 shall be binding upon Lead Purchaser and
the Company. 
 5.6 Headings. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not
be deemed to limit or affect any of the provisions hereof. 
 5.7 Successors and Assigns. This Agreement shall be binding upon and
inure to the benefit of the parties and their successors and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of Lead Purchaser (other than by merger). Lead
Purchaser may assign any or all of its rights under this Agreement to any Person to whom Lead Purchaser assigns or transfers any Shares, provided that such transferee agrees in writing to be bound, with respect to the transferred Shares, by the
provisions of the Transaction Documents that apply to “Lead Purchaser.” 
 5.8 No Third-Party Beneficiaries. This Agreement
is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person. 

5.9 Governing Law. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations,
enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, trustees,
employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York,
Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby
irrevocably waives, and agrees not to assert in any Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby
irrevocably waives personal service of process and consents to process being served in any such Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in
effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
other manner permitted by law.    If any party hereto shall commence an Proceeding to enforce any provisions of the Transaction Documents hereof, then, in addition to the obligations of the Company under Section 4.3, the
prevailing party in such Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and
prosecution of such Proceeding. 

  
 10 

 5.10 Survival. The representations, warranties, covenants and agreements contained
herein shall survive the Closing and the delivery of the Shares for the applicable statute of limitations. 
 5.11 Execution. This
Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it
being understood that the parties need not sign the same counterpart. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signatures complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com)
or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. 

5.12 Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be
invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall
use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be
the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable. 

5.13 Replacement of Shares. If any certificate or instrument evidencing any Shares is mutilated, lost, stolen or destroyed, the Company
shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably
satisfactory to the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including customary indemnity) associated with the issuance
of such replacement Shares. 
 5.14 Remedies. In addition to being entitled to exercise all rights provided herein or granted by law,
including recovery of damages, each of Lead Purchaser and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason
of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not to assert in any Proceeding for specific performance of any such obligation the defense that a remedy at law would be adequate. 

5.15 Payment Set Aside. To the extent that the Company makes a payment or payments to Lead Purchaser pursuant to any Transaction
Document or Lead Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential,

  
 11 

 
set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without
limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full
force and effect as if such payment had not been made or such enforcement or setoff had not occurred. 
 5.16 Saturdays, Sundays,
Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day. 
 5.17 Construction. The parties agree that each of them and/or their respective counsel have reviewed and had an
opportunity to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents
or any amendments thereto. In addition, each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and
other similar transactions of the Common Stock that occur after the date of this Agreement. 
 5.18 Further Assurances. The parties
shall execute and deliver all such further instruments and documents and take all such other actions as may reasonably be required to carry out the transactions contemplated hereby and to evidence the fulfillment of the agreements herein contained.

 5.19 WAIVER OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST
ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.  

(Signature Pages Follow) 

  
 12 

 IN WITNESS WHEREOF, the parties hereto have caused this Debt Exchange Agreement to be duly
executed by their respective authorized signatories as of the date first indicated above. 
  

							
	COMPANY:	 		 	Address for Notice:
			
	ALPHATEC HOLDINGS, INC.	 		 	Alphatec Holdings, Inc.
		 		 		 	Attn: General Counsel
		 		 		 	5818 El Camino Real
		 		 		 	Carlsbad, CA 92008
	By:	 	 /s/ Jeffrey Black
	 		 	Fax: (760) 431-9083
		 	Name: Jeffrey Black	 		 	
		 	Title: Chief Financial Officer	 		 	

  

	
	With a copy to (which shall not constitute notice):
	
	 Latham & Watkins LLP
 Attn: Matthew
Bush
 12670 High Bluff Drive
 San Diego, CA 92130

Fax: (858) 523-5450

 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK 

SIGNATURE PAGE FOR LEAD PURCHASER FOLLOWS] 

							
	LEAD PURCHASER:	 		 	Address for Notice:
			
	SQUADRON CAPITAL LLC	 		 	Squadron Capital LLC
		 		 		 	Attn: David R. Pelizzon
		 		 		 	18 Hartford Avenue
		 		 		 	Granby, CT 06035
	By:	 	 /s/ David R. Pelizzon
	 		 	
		 	Name: David R. Pelizzon	 		 	
		 	Title: President	 		 	

  

	
	With a copy to (which shall not constitute notice):
	
	 Reed Smith LLP
 Attn: Joel Schaider

10 South Wacker Drive, 40th Floor

Chicago, IL 60606
 Fax: (312)
207-1000EX-10.3

 Exhibit 10.3 

Execution Version 
 THIRD
AMENDMENT TO 
 CREDIT, SECURITY AND GUARANTY AGREEMENT 

This THIRD AMENDMENT TO CREDIT, SECURITY AND GUARANTY AGREEMENT (this “Amendment”) is entered into as of December 16, 2020, by and among
ALPHATEC HOLDINGS, INC., a Delaware corporation, ALPHATEC SPINE, INC., a California corporation and SAFEOP SURGICAL, INC., a Delaware corporation (each individually as a “Borrower” and collectively, as
“Borrowers”) and SQUADRON MEDICAL FINANCE SOLUTIONS LLC, a Delaware limited liability company as lender (“Lender”). 

RECITALS: 
 A. Lender made
loans and certain other financial accommodations to Borrowers as evidenced by that certain Credit, Security and Guaranty Agreement dated as of November 6, 2018 by and among Borrowers and Lender (as amended or modified to date, the
“Existing Credit, Security and Guaranty Agreement”). 
 B. Borrowers and Lender desire to exchange $30,000,000 of
the Existing Term Loan (as defined in the Existing Credit, Security and Guaranty Agreement) for shares of common stock of Alphatec Holdings, Inc., pursuant to the terms of a certain debt exchange agreement dated as of the date hereof between
Alphatec Holdings, Inc. and Squadron Capital LLC (“Debt Exchange Agreement”); and 
 C. Borrowers and Lender hereby agree
to amend the Existing Credit, Security and Guaranty Agreement to reflect the Existing Term Loan as adjusted for the aforementioned debt exchange and to make such other changes as described in this Amendment. 

NOW, THEREFORE, in consideration of the foregoing Recitals, which are hereby incorporated into this Amendment and made a part hereof, and for
good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 
 1.
Incorporation of Recitals. Borrowers and Lender hereby agree that all of the Recitals in this Amendment are hereby incorporated into and made a part hereof. 

2. Capitalized Terms. Except as otherwise defined in this Amendment, each capitalized term used herein shall have the same meaning as
that assigned to it in the Existing Credit, Security and Guaranty Agreement, and such definitions shall be incorporated herein by reference, as if fully set forth herein. 

3. Amendments to Existing Credit, Security and Guaranty Agreement. 

A. Section 1.1 of the Existing Credit, Security and Guaranty Agreement is hereby amended by adding
the following definitions in the appropriate alphabetical location: 
 “Debt Exchange Agreement” means that
certain Debt Exchange Agreement dated as of the Third Amendment Effective Date between Alphatec Holdings, Inc. and Squadron Capital LLC. 

“EOS imaging S.A. Transaction” means the acquisition of EOS imaging S.A. by means a of a public tender offer
pursuant to the terms of that certain Tender Offer Agreement, dated as of December 16, 2020, by and between Alphatec Holdings, Inc. and EOS imaging S.A., a société anonyme organized and existing under the laws of France. 

 “Third Amendment Effective Date” means December 16,
2020. 
 B. Clause (l) of the definition of “Permitted Investments” in Section 1.1
of the Existing Credit, Security and Guaranty Agreement is hereby amended and restated as follows: 
 (l) the EOS imaging
S.A. Transaction. 
 C. The definition of “Termination Date” in Section 1.1 of the
Existing Credit, Security and Guaranty Agreement is hereby amended and restated as follows: 
 “Termination
Date” means the earlier to occur of (a) June 30, 2026, (b) any date on which Lender accelerates the maturity of the Term Loan pursuant to Section 10.2, or (c) the termination date stated in any
notice of termination of this Agreement provided by Borrowers in accordance with Section 2.8. 
 D.
Section 2.1(a) of the Existing Credit, Security and Guaranty Agreement is hereby amended and restated as follows: 

(a) Term Loan Amount. 

(i) Borrowers and Lender acknowledge that Lender has made a term loan to Borrowers in the aggregate original principal amount
equal to $45,000,000 (“Existing Term Loan”). 
 (ii) On the terms and conditions set forth herein, Lender
agrees to make to Borrowers an additional term loan in the aggregate principal amount equal to $40,000,000 (“Additional Term Loan” and together with the Existing Term Loan, the “Term Loan”). Each drawing by
Borrowers under the Additional Term Loan shall be subject to the following conditions: 
 (A) no Default or Event of Default
shall occur or be continuing before and after giving effect to such drawing by Borrowers under the Additional Term Loan; 

(B) proceeds of all drawings by Borrowers under the Additional Term Loan shall be used for working capital and general
corporate purposes of the Borrowers; 
 (C) Borrowers shall give Lender a written notice specifying the amount Borrowers
desire to draw under the Additional Term Loan not less than fifteen (15) days before each drawing; 
 (D) there shall
be no more than two drawings in any calendar month; 
 (E) drawings of the Additional Term Loan which are prepaid, whether
by mandatory or optional prepayments, may be reborrowed; 

  
 2 

 (F) each drawing by Borrowers under the Additional Term Loan shall be in a
minimum amount of $1,000,000 and incremental amounts in integral multiples of $100,000; and 
 (G) no drawing by Borrowers
under the Additional Term Loan shall be made following the Termination Date. 
 E.
Section 2.1(b)(i) of the Existing Credit, Security and Guaranty Agreement is hereby amended and restated as follows: 

(i) There shall become due and payable, and Borrowers shall repay the Existing Term Loan through scheduled payments beginning
on December 31, 2023 and continuing on the last Business Day of each month thereafter, in monthly principal payments of $1,000,000. Notwithstanding the foregoing, the outstanding principal amount of the Term Loan shall become immediately due
and payable in full on the Termination Date. 
 F. Section 2.1(b) of the Existing Credit, Security and Guaranty
Agreement is hereby amended to add the following new subsection (iv) as follows: 
 (iv) Notwithstanding anything in
this Agreement to the contrary, the Debt Exchange Agreement amends this Agreement by reducing the Existing Term Loan in the principal amount of the Existing Term Loan by $30,000,000 in exchange for 2,700,270 shares of common stock of Alphatec
Holdings, Inc. with no other fees or other amounts payable other than as provided in the Debt Exchange Agreement. For purposes of this Section 2.1(b)(iv) only, “Existing Term Loan” shall mean $65,000,000. 

G. Section 2.1(d)(i) of the Existing Credit, Security and Guaranty Agreement is hereby amended and
restated as follows: 
 (i) Except as provided in subsection (ii) below, the Term Loan shall accrue interest at
the LIBOR Rate plus the Applicable Margin; provided, however, that in no event shall interest accrue at a rate lower than 9% per annum or greater than 12% per annum. 

H. Section 2.1(e) of the Existing Credit, Security and Guaranty Agreement is hereby amended to add the following sentence
at the end of subparagraph (ii) thereof: 
 For purposes of this Section 2.1(e) only, (i) “Initial Term
Loan” shall mean $35,000,000, (ii) “Existing Term Loan” shall mean $65,000,000 and (iii) “Additional Term Loan” shall mean $35,000,000. 

I. Section 2.2 of the Existing Credit, Security and Guaranty Agreement is hereby amended to add the
following new subsection (f) as follows: 
 (f) Undrawn Fee. For the period from and including the Third
Amendment Effective Date to the Termination Date, Borrowers shall pay to Lender an unused fee equal to 1% per annum (compounded on the basis of a year of 360 days and the actual number of days elapsed) times the daily undrawn portion of the
Additional Term Loan. Such undrawn fee shall be payable quarterly in arrears on March 31, June 30, September 30 and December 31 of each year (commencing on the first such date occurring after the date hereof) and on the
Termination Date. 

  
 3 

 J. Section 2.3 of the Existing Credit, Security
and Guaranty Agreement is hereby amended and restated as follows: 
 Section 2.3 Term Note.
The Term Loan made by Lender shall be evidenced by a third amended and restated promissory note in the form attached hereto as Exhibit A executed by Borrowers on a joint and several basis (as amended and restated, “Term
Note”) in an original principal amount equal to Eighty Five Million Dollars ($85,000,000). 
 K. Schedule 2.1
of the Existing Credit, Security and Guaranty Agreement is hereby replaced in its entirety with Schedule 2.1 attached hereto. 

L. Exhibit A of the Existing Credit, Security and Guaranty Agreement is hereby replaced in its entirety with Exhibit
A attached hereto. 
 4. Representations, Warranties and Covenants. Each Borrower hereby represents, warrants and covenants to
Lender as follows: 
 A. no Unmatured Default or Event of Default has occurred and is continuing under the Existing Credit, Security and
Guaranty Agreement or any other Loan Document; 
 B. the representations and warranties of Borrowers in the Existing Credit, Security and
Guaranty Agreement and each other Loan Document are true and correct in all material respects as of the date hereof as though each of said representations and warranties was made on the date hereof (except, in each case for representations and
warranties which by their terms are expressly applicable to an earlier date, in which case, such representations and warranties shall be true and correct in all material respects as of such earlier date); and 

C. this Amendment has been duly authorized, executed and delivered on behalf of Borrowers and this Amendment constitutes the legal, valid and
binding obligation of Borrowers, enforceable in accordance with its terms except as enforceability may be limited by applicable bankruptcy, insolvency or laws affecting creditor’s rights generally and by general principles of equity. 

5. Conditions Precedent. The obligation of Lender to enter into this Amendment is subject to the following conditions precedent: 

A. Borrowers shall have entered into or caused to be entered into, executed and delivered to Lender: 

 

	 	(i)	 a fully executed signature page to this Amendment, 

 

	 	(ii)	 a fully executed Debt Exchange Agreement; 

 

	 	(iii)	 the Third Amended and Restated Term Note in the form attached hereto as Exhibit A; and

  

	 	(iv)	 such consents and approvals acceptable to Lender. 

  
 4 

 B. Lender shall have received a certificate from the Secretary of each Borrower
(i) attesting to the resolutions of the Board of Directors authorizing its execution, delivery and performance of this Amendment, (ii) authorizing specific officers of Borrower to execute this Amendment, and (iii) attesting to the
incumbency and signature of specific officers of Borrower. 
 C. Borrowers shall reimburse all reasonable and documented fees and expenses
of Lender’s counsel in connection with this Amendment. 
 7. Waiver of Claims. As of the date hereof, each Borrower hereby
acknowledges, agrees and affirms that it currently possesses no claims, defenses, offsets, recoupment or counterclaims of any kind or nature against or with respect to the enforcement of the Existing Credit, Security and Guaranty Agreement or any
other Loan Document or any amendments thereto (collectively, the “Claims”), nor does any Borrower have knowledge of any facts that would or might give rise to any Claims. If facts now exist which would or could give rise to any
Claim against or with respect to the enforcement of the Existing Credit, Security and Guaranty Agreement or any other Loan Document, as amended hereby, each Borrower hereby unconditionally, irrevocably and unequivocally waives to the extent
permitted by applicable law and fully releases any and all such Claims as if such Claims were the subject of a lawsuit (other than the defense of payment in full), adjudicated to final judgment from which no appeal could be taken and therein
dismissed with prejudice. 
 8. Ratification of Existing Credit, Security and Guaranty Agreement and the other Loan Documents. From
and after the date hereof, the Existing Credit, Security and Guaranty Agreement and the other Loan Documents shall be deemed to be amended and modified as provided herein and in the Debt Exchange Agreement, and, except as so amended and modified,
the Existing Credit, Security and Guaranty Agreement and the other Loan Documents shall continue in full force and effect and the Existing Credit, Security and Guaranty Agreement and the applicable provisions of this Amendment and the Debt Exchange
Agreement shall be read, taken and construed as one and the same instrument. Each Borrower hereby remakes, ratifies and reaffirms all of its Obligations under the terms of the Existing Credit, Security and Guaranty Agreement and the other Loan
Documents and any other document to which it is a party evidencing, creating or securing the Term Loan, as of the date hereof after giving effect to the amendments contained herein including, without limitation, the granting of a security interest
thereunder. On and after the date hereof, the term “Credit, Security and Guaranty Agreement” used in any document evidencing the Term Loan shall mean the Existing Credit, Security and Guaranty Agreement as amended pursuant to this
Amendment and the Debt Exchange Agreement. Except as expressly set forth in this Amendment, nothing in this Amendment shall constitute a waiver or relinquishment of (a) any Default or Event of Default under any of the Loan Documents,
(b) any of the agreements, terms or conditions contained in any of the Loan Documents, (c) any rights or remedies of Lender with respect to the Loan Documents, or (d) the rights of Lender to collect the full amounts owing to them
under the Loan Documents. 
 9. Consents. Each Borrower hereby represents that this Amendment does not violate any material provision
of any instrument, document, contract or agreement to which such party is a party, or each Borrower hereby represents that it has obtained all requisite consents under those third party instruments prior to entering into this Amendment. 

10. Further Assurances. The parties hereto, shall, at any time and from time to time, following the execution of this Amendment,
execute and deliver all such further instruments and take all such further action as may be reasonably necessary or appropriate in order to carry out the provisions of this Amendment. 

  
 5 

 11. Counterparts. This Amendment may be executed in any number of counterparts, and
by the different parties hereto and thereto on the same or separate counterparts, each of which, when so executed and delivered, shall be deemed to be an original; all the counterparts for this Amendment shall together constitute one and the same
agreement. Delivery of a counterpart to this Amendment by facsimile or electronic transmission shall constitute delivery of an original counterpart hereto. 

12. Representation by Counsel. Each Borrower hereby represents that it has been represented by competent counsel of its choice in the
negotiation and execution of this Amendment; that it has read and fully understands the terms hereof, that such party and its counsel have been afforded an opportunity to review, negotiate and modify the terms of this Amendment, and that it intends
to be bound hereby. 
 13. No Third Party Beneficiaries. The terms and provisions of this Amendment shall be for the sole benefit of
the parties hereto and their respective successors and assigns; no other person, firm, entity or corporation shall have any right, benefit or interest under this Amendment. 

14. Governing Law and Submission to Jurisdiction. The provision of Section 11.8 of the Existing Credit,
Security and Guaranty Agreement is hereby incorporated herein by reference. 
 15. WAIVER OF JURY TRIAL. EACH BORROWER AND LENDER
HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THE FINANCING DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED THEREBY AND AGREES THAT ANY SUCH ACTION OR PROCEEDING SHALL BE
TRIED BEFORE A COURT AND NOT BEFORE A JURY. EACH BORROWER AND LENDER ACKNOWLEDGES THAT THIS WAIVER IS A MATERIAL INDUCEMENT TO ENTER INTO A BUSINESS RELATIONSHIP, THAT EACH HAS RELIED ON THE WAIVER IN ENTERING INTO THIS AMENDMENT AND THE OTHER
FINANCING DOCUMENTS, AND THAT EACH WILL CONTINUE TO RELY ON THIS WAIVER IN THEIR RELATED FUTURE DEALINGS. EACH BORROWER AND LENDER WARRANTS AND REPRESENTS THAT IT HAS HAD THE OPPORTUNITY OF REVIEWING THIS JURY WAIVER WITH LEGAL COUNSEL, AND THAT IT
KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS. 
 THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK. 

  
 6 

 IN WITNESS WHEREOF, the parties hereto have executed this Third Amendment to Credit,
Security and Guaranty Agreement dated as of the date first written above. 
  

			
	ALPHATEC HOLDINGS, INC.,
	a Delaware corporation
		
	By:	 	/s/ Jeffrey Black
		 	Jeffrey Black
		 	Chief Financial Officer
	
	ALPHATEC SPINE, INC.
	a California corporation
		
	By:	 	/s/ Jeffrey Black
		 	Jeffrey Black
		 	Chief Financial Officer
	
	SAFEOP SURGICAL, INC.
	a Delaware corporation
		
	By:	 	/s/ Jeffrey Black
		 	Jeffrey Black
		 	Chief Financial Officer

 Third Amendment to 

Credit, Security and Guaranty Agreement 

 
			
	LENDER:
	
	SQUADRON MEDICAL FINANCE SOLUTIONS, LLC
		
	By:	 	/s/ David Pelizzon
		 	David Pelizzon
		 	President

 Third Amendment to 

Credit, Security and Guaranty Agreement 

 Exhibit A 

Form of Third Amended and Restated Term Note 
  

			
	$85,000,000	  	December __, 2020

 FOR VALUE RECEIVED, the undersigned (individually, a “Borrower” and, collectively, the
“Borrowers”), jointly and severally promise to pay to the order of Squadron Medical Finance Solutions LLC, a Delaware limited liability company (hereinafter, with any subsequent holders, the “Lender”), 18
Hartford Avenue, Granby, CT 06035, the principal sum of EIGHTY FIVE MILLION DOLLARS ($85,000,000), made by the Lender to or for the account of the Borrowers pursuant to the Credit, Security and Guaranty Agreement dated as of November 6, 2018
(as amended, modified, supplemented or restated and in effect from time to time, the “Credit Agreement”) by and among the Borrowers, the other Credit Parties from time to time party thereto, and the Lender, with interest at the rate
and payable in the manner stated therein. 
 This is a promissory note (“Term Note”) to which reference is made in Section 2.3 of the
Credit Agreement and is subject to all terms and provisions thereof. The principal of, and interest on, this Term Note shall be payable at the times, in the manner, and in the amounts as provided in the Credit Agreement and shall be subject to
prepayment and acceleration as provided therein. Capitalized terms used herein and not defined herein shall have the meanings assigned to such terms in the Credit Agreement. 

The Lender’s books and records concerning the Term Loan, the accrual of interest thereon, and the repayment of such Term Loan, shall be prima facie
evidence of the indebtedness to the Lender hereunder. 
 No delay or omission by the Lender in exercising or enforcing any of the Lender’s powers,
rights, privileges, remedies, or discretions hereunder shall operate as a waiver thereof on that occasion nor on any other occasion. No waiver of any Event of Default shall operate as a waiver of any other Event of Default. 

This Term Note shall be binding upon each Borrower, and each endorser and guarantor hereof, and upon their respective successors, assigns, and
representatives, and shall inure to the benefit of the Lender and its successors, endorsees, and assigns. 
 This Term Note amends and restates that certain
Amended and Restated Term Note dated as of May 30, 2020 made by Borrowers in favor of Lender in the original principal amount of $100,000,000 (the “Existing Term Note”) and constitutes a replacement and substitute for the
Existing Term Note. To the extent that the principal balance of this Term Note includes the indebtedness hitherto evidenced by the Existing Term Note, the indebtedness evidenced by the Existing Term Note is a continuing indebtedness and nothing
herein shall be deemed to constitute a payment, settlement or novation of the Existing Term Note or a release of any collateral heretofore pledged to secure payment and performance of the Existing Term Note, all such collateral hereby expressly
pledged to secure the payment and performance of the obligations hereunder as if fully set forth herein. 
 THIS TERM NOTE AND ALL MATTERS RELATING HERETO
OR ARISING HEREFROM (WHETHER SOUNDING IN CONTRACT LAW, TORT LAW OR OTHERWISE), SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO CONFLICTS OF LAWS PRINCIPLES. 

 EACH BORROWER HEREBY CONSENTS TO THE JURISDICTION OF ANY STATE OR FEDERAL COURT LOCATED WITHIN THE COUNTY OF
NEW YORK COUNTY, STATE OF NEW YORK AND IRREVOCABLY AGREES THAT, SUBJECT TO LENDER’S ELECTION, ALL ACTIONS OR PROCEEDINGS ARISING OUT OF OR RELATING TO THIS AGREEMENT SHALL BE LITIGATED IN SUCH COURTS. EACH BORROWER EXPRESSLY SUBMITS AND
CONSENTS TO THE JURISDICTION OF THE AFORESAID COURTS AND WAIVES ANY DEFENSE OF FORUM NON CONVENIENS. EACH BORROWER HEREBY WAIVES PERSONAL SERVICE OF ANY AND ALL PROCESS AND AGREES THAT ALL SUCH SERVICE OF PROCESS MAY BE MADE UPON SUCH BORROWER BY
CERTIFIED OR REGISTERED MAIL, RETURN RECEIPT REQUESTED, ADDRESSED TO SUCH BORROWER AT THE ADDRESS SET FORTH IN THE CREDIT AGREEMENT AND SERVICE SO MADE SHALL BE COMPLETE TEN (10) DAYS AFTER THE SAME HAS BEEN POSTED. 

EACH BORROWER, AND LENDER BY ITS ACCEPTANCE HEREOF, HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING ARISING OUT
OF OR RELATING TO THIS TERM NOTE OR THE TRANSACTIONS CONTEMPLATED THEREBY AND AGREES THAT ANY SUCH ACTION OR PROCEEDING SHALL BE TRIED BEFORE A COURT AND NOT BEFORE A JURY. EACH BORROWER AND LENDER ACKNOWLEDGES THAT THIS WAIVER IS A MATERIAL
INDUCEMENT TO ENTER INTO A BUSINESS RELATIONSHIP, THAT EACH HAS RELIED ON THE WAIVER IN ISSUING AND ACCEPTING THIS TERM NOTE, AND THAT EACH WILL CONTINUE TO RELY ON THIS WAIVER IN THEIR RELATED FUTURE DEALINGS. EACH BORROWER AND LENDER WARRANTS AND
REPRESENTS THAT IT HAS HAD THE OPPORTUNITY OF REVIEWING THIS JURY WAIVER WITH LEGAL COUNSEL, AND THAT IT KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS. 

[SIGNATURE PAGE FOLLOWS] 

  
 - 2 - 

 IN WITNESS WHEREOF, the Borrowers have caused this Term Note to be duly executed as of the
date set forth above. 
  

			
	ALPHATEC HOLDINGS, INC.
		
	By:	 	            
	Name: Jeffrey Black
	Title: Chief Financial Officer
	
	ALPHATEC SPINE, INC.
		
	By:	 	            
	Name: Jeffrey Black
	Title: Chief Financial Officer
	
	SAFEOP SURGICAL, INC.
		
	By:	 	                
	Name: Jeffrey Black
	Title: Chief Financial Officer

 Schedule 2.1 

AMORTIZATION OF EXISTING TERM LOAN 
  

			
	 Payment Date
	  	 Amount

		
	 December 31, 2023 through June 30, 2026
	  	$1,000,000
		
	 June 30, 2026
	  	Outstanding balance of all principal and interest

 Notice of Exercise – Warrant – Alphatec Holdings, Inc.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}]]